Amgen Strengthens Osteoporosis Outreach and Wins Domain Dispute
Oct/14/2025
Amgen has filed a new U.S. trademark for 'Fracture Care Gap: Prioritizing Osteoporosis Care', covering online educational services such as podcasts, videos, and healthcare resources aimed at improving post-fracture osteoporosis treatment. The filing, accompanied by a matching domain registration, underscores the biotech leader’s push to raise awareness of bone health—one of its long-standing therapeutic areas alongside oncology and cardiovascular disease. The move follows a favorable WIPO ruling in October ordering the transfer of amgens-inc.com to Amgen, after it was found to have been used in a scheme impersonating the company’s supply-chain executive. With $33.4 billion in 2024 revenue and roughly 27,000 employees, the California-based firm continues to channel nearly a fifth of its income into research and development, focusing on innovation in chronic and degenerative conditions.
